Skandinaviska Enskilda Banken (SEB)’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-8,700
Closed -$209K 918
2019
Q2
$209K Sell
8,700
-18,599
-68% -$548K ﹤0.01% 772
2019
Q1
$1.01M Sell
27,299
-6,226
-19% -$227K 0.01% 593
2018
Q4
$946K Buy
33,525
+5,326
+19% +$168K 0.01% 660
2018
Q3
$1.11M Hold
28,199
0.01% 655
2018
Q2
$1.25M Buy
28,199
+1,900
+7% +$94.5K 0.01% 582
2018
Q1
$1.28M Buy
26,299
+1,899
+8% +$94.9K 0.01% 524
2017
Q4
$1.22M Buy
+24,400
New +$1.28M 0.01% 572

Other funds holding CC

Skandinaviska Enskilda Banken (SEB)'s CC Position: Q3 2019 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Chemours (CC) in Q3 2019, closing a stake of 8,700 shares — an estimated $209K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in CC in Q4 2017 and held it in 7 quarters. The position peaked at $1.28M in Q1 2018. 419 funds tracked by Wall St. Rank hold CC as of Q3 2019.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Chemours position as of Q3 2019 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 8,700 Chemours shares in Q3 2019, an estimated $209K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Chemours in Q4 2017 and held it in 7 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Chemours position peaked at $1.28M in Q1 2018.
  • 419 funds tracked by Wall St. Rank held Chemours as of Q3 2019.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2019, filed 8 Nov 2019.